Nebenwirkungen · Ferriprox
Ferriprox 500 mg film-coated tablets Ferriprox 1 000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-089835 · Präparat HOS-083927
System organ class Very common Common Frequency not (≥ 1/10) (≥ 1/100 to < 1/10) known Blood and lymphatic system Neutropenia disorders Agranulocytosis Immune system disorders Hypersensitivity reactions Metabolism and nutrition Increased appetite disorders Nervous system disorders Headache Gastrointestinal disorders Nausea Diarrhoea Abdominal pain Vomiting Skin and subcutaneous tissue Rash disorders Urticaria Musculoskeletal and Arthralgia connective tissue disorders Renal and urinary disorders Chromaturia General disorders and Fatigue administration site conditions Investigations Increased liver enzymes
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-21T02:00:00Z · SHA-256 8d30ff208e2cac65daccef3e0bb072261a28975145087d11012d5a853f6fab1e · Passage 7b0bc87c2cefd5ca3a544340ddec5fb88f130cbcb9b312cbbf7fa5bcff71a97b · Zeichen 738–2110 im Abschnitt